DAY ONE WEDNESDAY, FEBRUARY 6, 2019
7:30
Conference Registration and Continental Breakfast
8:30
Workshop Leaders’ Welcome and Opening Remarks
CHOOSE BETWEEN TWO IN-CONFERENCE WORKSHOPS (A-B)
WORKSHOP A
Process, Tools and Considerations in Building Your IISR
WORKSHOP LEADERS:
Jan Fourman, PhD
Regulatory Scientist, Biotechnology Innovation and Regulatory Science (BIRS) Center
Purdue University
Sloan Stribling
Associate Director, Primary Care Team Lead
Merck
WORKSHOP B
Navigate the Complexities of Budgeting and
Contracting to Improve Timelines
WORKSHOP LEADERS:
Terry Burton
Associate Director, Clinical Contracts & Finance
Gilead Sciences
Dianne Archer
Corporate Counsel
Gilead Sciences
Jon Behrens
Senior Manager, Clinical Contracts & Finance
Gilead Sciences
Annmarie Galli
Head, Global Medical Affairs Research
TESARO
There will be a 30-minute networking and refreshment break at 10:00 a.m.
12:00
Networking Luncheon
1:00
Chairperson's Welcome & Opening Remarks
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
1:15
OPENING ADDRESS FDA Registration Studies in the Cooperative Group Setting
Nathan Eriksen
Chief Administration, SWOG
Oregon Health & Science University
How to Build and Maintain Successful IISR Programs
2:00
Guidance for Developing a Global IISR Process
Joe Kerkering, MBA
Director, Global Medical Affairs Operations
Incyte Corporation
2:45
Doing More with Less — Scalable Solutions to Improve Program Development
Kelli Walker, PharmD, MS
Portfolio Manager
Envision Technology Solutions
3:30
Networking and Refreshment Break
4:00
CASE STUDY Build an Investigator-Sponsored Research Unit from Scratch
Michael C. Oldfield, JD, MBA, CCRP
Director, Regulatory Affairs & ISRU
Fox Chase Cancer Center
Approaches to Improve Your IISR Programs
4:45
CASE STUDY Process Improvement — The Ever-Changing World of IISRs
Carol Richardson
Senior Research Data Coordinator
Abbott Nutrition
Janice Fonarow, RD, LD
Senior Clinical Research Associate
Abbott Nutrition
5:45
Close of Day One
Networking, Wine and Cheese Reception immediately following the final session on day one
DAY TWO THURSDAY, FEBRUARY 7, 2019
7:30
Continental Breakfast
8:00
Chairperson's Review of Day One
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
8:15
Tips and Traps When Allocating Risk in Investigator Initiated Sponsored Research Agreements (IISRAs)
Marlon Rajakaruna
Partner and Global Co-Leader, Life Sciences and Healthcare Practice Groups
Dentons
9:00
Determining FMV for IISRs
John Moose
Principal
Polaris
9:45
FIRESIDE CHAT Manage Interaction with Investigators
MODERATOR:
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
CONVERSATION CONTRIBUTORS:
Alison Urton
Group Administrator
Canadian Cancer Trials Group (CCTG)
Alyssa Truong, MPH
Senior Manager, Medical Affairs
Jazz Pharmaceuticals
10:30
Networking and Refreshment Break
11:00
Site Perspectives on IISR Success — Getting the Most from Your KOLs and IISRs
Christy Gilchrist, PhD
Director, Clinical Programs
HHS St. Vincent Hospital
11:45
FIRESIDE CHAT Establish the Value of IISR Programs to Internal Stakeholders
CONVERSATION CONTRIBUTORS:
Alyssa Truong, MPH
Senior Manager, Medical Affairs
Jazz Pharmaceutical
Michael Martineau
Senior Manager, Global Medical Operations
Ipsen Biopharmaceuticals
12:30
Networking Luncheon
The Evolution of Collaborative Studies
1:30
PANEL DISCUSSION Defining Investigator Initiated Sponsored Versus Collaborative Research
MODERATOR:
Ashley Wills
Senior Director, Global Medical Affairs Strategic Initiatives & Research
TESARO
PANELISTS:
Dana Sparks
Director of Operations and Protocols
SWOG
Nathan Eriksen
Chief Administration
SWOG
Alison Urton
Group Administrator
Canadian Cancer Trials Group (CCTG)
Christy Gilchrist, PhD
Director, Clinical Programs
HHS St. Vincent Hospital
2:30
ROUNDTABLE DISCUSSION Harmonize IST Programs Across Industry
FACILITATOR:
Ashley Wills
Senior Director, Global Medical Affairs Strategic Initiatives & Research
TESARO
3:15
Close of Conference
DAY ONE WEDNESDAY, FEBRUARY 6, 2019
7:30
Conference Registration and Continental Breakfast
8:30
Workshop Leaders’ Welcome and Opening Remarks
CHOOSE BETWEEN TWO IN-CONFERENCE WORKSHOPS (A-B)
WORKSHOP A
Process, Tools and Considerations in Building Your IISR
WORKSHOP LEADERS:
Jan Fourman, PhD
Regulatory Scientist, Biotechnology Innovation and Regulatory Science (BIRS) Center
Purdue University
Sloan Stribling
Associate Director, Primary Care Team Lead
Merck
WORKSHOP B
Navigate the Complexities of Budgeting and
Contracting to Improve Timelines
WORKSHOP LEADERS:
Terry Burton
Associate Director, Clinical Contracts & Finance
Gilead Sciences
Dianne Archer
Corporate Counsel
Gilead Sciences
Jon Behrens
Senior Manager, Clinical Contracts & Finance
Gilead Sciences
Annmarie Galli
Head, Global Medical Affairs Research
TESARO
There will be a 30-minute networking and refreshment break at 10:00 a.m.
12:00
Networking Luncheon
1:00
Chairperson's Welcome & Opening Remarks
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
1:15
OPENING ADDRESS FDA Registration Studies in the Cooperative Group Setting
Nathan Eriksen
Chief Administration, SWOG
Oregon Health & Science University
How to Build and Maintain Successful IISR Programs
2:00
Guidance for Developing a Global IISR Process
Joe Kerkering, MBA
Director, Global Medical Affairs Operations
Incyte Corporation
2:45
Doing More with Less — Scalable Solutions to Improve Program Development
Kelli Walker, PharmD, MS
Portfolio Manager
Envision Technology Solutions
3:30
Networking and Refreshment Break
4:00
CASE STUDY Build an Investigator-Sponsored Research Unit from Scratch
Michael C. Oldfield, JD, MBA, CCRP
Director, Regulatory Affairs & ISRU
Fox Chase Cancer Center
Approaches to Improve Your IISR Programs
4:45
CASE STUDY Process Improvement — The Ever-Changing World of IISRs
Carol Richardson
Senior Research Data Coordinator
Abbott Nutrition
Janice Fonarow, RD, LD
Senior Clinical Research Associate
Abbott Nutrition
5:45
Close of Day One
Networking, Wine and Cheese Reception immediately following the final session on day one
DAY TWO THURSDAY, FEBRUARY 7, 2019
7:30
Continental Breakfast
8:00
Chairperson's Review of Day One
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
8:15
Tips and Traps When Allocating Risk in Investigator Initiated Sponsored Research Agreements (IISRAs)
Marlon Rajakaruna
Partner and Global Co-Leader, Life Sciences and Healthcare Practice Groups
Dentons
9:00
Determining FMV for IISRs
John Moose
Principal
Polaris
9:45
FIRESIDE CHAT Manage Interaction with Investigators
MODERATOR:
Theresa Bucher
Associate Director, Global Medical Affairs Research
Takeda
CONVERSATION CONTRIBUTORS:
Alison Urton
Group Administrator
Canadian Cancer Trials Group (CCTG)
Alyssa Truong, MPH
Senior Manager, Medical Affairs
Jazz Pharmaceuticals
10:30
Networking and Refreshment Break
11:00
Site Perspectives on IISR Success — Getting the Most from Your KOLs and IISRs
Christy Gilchrist, PhD
Director, Clinical Programs
HHS St. Vincent Hospital
11:45
FIRESIDE CHAT Establish the Value of IISR Programs to Internal Stakeholders
CONVERSATION CONTRIBUTORS:
Alyssa Truong, MPH
Senior Manager, Medical Affairs
Jazz Pharmaceutical
Michael Martineau
Senior Manager, Global Medical Operations
Ipsen Biopharmaceuticals
12:30
Networking Luncheon
The Evolution of Collaborative Studies
1:30
PANEL DISCUSSION Defining Investigator Initiated Sponsored Versus Collaborative Research
MODERATOR:
Ashley Wills
Senior Director, Global Medical Affairs Strategic Initiatives & Research
TESARO
PANELISTS:
Dana Sparks
Director of Operations and Protocols
SWOG
Nathan Eriksen
Chief Administration
SWOG
Alison Urton
Group Administrator
Canadian Cancer Trials Group (CCTG)
Christy Gilchrist, PhD
Director, Clinical Programs
HHS St. Vincent Hospital
2:30
ROUNDTABLE DISCUSSION Harmonize IST Programs Across Industry
FACILITATOR:
Ashley Wills
Senior Director, Global Medical Affairs Strategic Initiatives & Research
TESARO
3:15
Close of Conference